K. Satani

Hepatocyte growth factor, a biomarker of macroangiopathy in diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2014, World journal of diabetes.

Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2010, Metabolism: clinical and experimental.

Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus.

M. Namba, T. Hamaguchi, J. Miyagawa, 2015, World journal of experimental medicine.

Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes

M. Namba, T. Hamaguchi, T. Katsuno, 2006, Diabetic medicine : a journal of the British Diabetic Association.